Related Experiment Videos

Enhanced expression of TGF-beta 1 by peritoneal macrophages in CAPD patients

T Wang1, Y G Ghen, R G Ye

  • 1National Institute of Kidney, Sun Yat-sen University of Medical Sciences, Guangzhou, People's Republic of China.

Insights

Peritoneal macrophages in dialysis fluid show increased transforming growth factor beta 1 (TGF-β1) mRNA. This indicates activated macrophages contribute to peritoneal fibrosis in continuous ambulatory peritoneal dialysis (CAPD) patients.

Area of Science:

  • Nephrology
  • Cell Biology
  • Immunology

Background:

  • Peritoneal macrophages are key cells in peritoneal dialysate.
  • Peritoneal fibrosis is a complication in long-term continuous ambulatory peritoneal dialysis (CAPD).

Purpose of the Study:

  • To investigate the role of peritoneal macrophages in peritoneal fibrosis.
  • To measure transforming growth factor beta 1 (TGF-β1) mRNA expression in peritoneal macrophages from CAPD patients.

Main Methods:

  • Macrophages were isolated from peritoneal dialysate and during catheter insertion.
  • Transforming growth factor beta 1 (TGF-β1) mRNA levels were quantified using slot-blot hybridization and a cDNA probe.

Main Results:

  • TGF-β1 mRNA expression was significantly elevated in macrophages from peritoneal dialysate compared to those from catheter insertion.
  • This suggests peritoneal macrophages in dialysate are activated.

Conclusions:

  • Peritoneal macrophages play a role in the pathogenesis of peritoneal fibrosis in CAPD patients.
  • Activated peritoneal macrophages in dialysate may contribute to fibrosis development.

Related Concept Videos